ALOXE3 and cancer: We conducted a pan-cancer Kaplan–Meier survival analysis for ALOXE3 and found that it serves as a better prognostic indicator in glioblastoma multiforme (GBM), while it is associated with unfavorable outcomes in colon adenocarcinoma (COAD) and uterine corpus endometrial carcinoma (UCEC) (Fig. S6).